Literature DB >> 21167220

Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4).

Delvac Oceandy1, Tamer M A Mohamed, Elizabeth J Cartwright, Ludwig Neyses.   

Abstract

Calcium has been unequivocally regarded as a key signal messenger in almost every cell type. Calcium regulates a number of important cellular functions including cell growth, myofilament contraction, cell survival and apoptosis as well as gene transcription. A complex regulatory mechanism of cellular calcium is needed to fine tune the precise calcium concentration in each subcellular location and also to transmit the signals carried by the calcium pool to the correct end target. In this article we will review the recently emerging role of the plasma membrane calcium/calmodulin dependent ATPase isoform 4 (PMCA4) in regulating calcium signalling. We will then focus on the function of this molecule in cardiomyocytes, in which PMCA4 forms protein-protein interactions with several key signalling molecules. Recent evidence has shown in vivo physiological functionalities and possible clinical implications of the PMCA4 signalling complex. This article is part of a Special Issue entitled: 11th European Symposium on Calcium. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167220     DOI: 10.1016/j.bbamcr.2010.12.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism.

Authors:  Namita Ganesh Hattangady; Jessica Foster; Antonio Marcondes Lerario; Daniela Ponce-Balbuena; Juilee Rege; Silvia Monticone; William E Rainey; Paolo Mulatero; Tobias Else
Journal:  Horm Cancer       Date:  2020-01-30       Impact factor: 3.869

2.  Plasma membrane calcium ATPase 4b inhibits nitric oxide generation through calcium-induced dynamic interaction with neuronal nitric oxide synthase.

Authors:  Wenjuan Duan; Juefei Zhou; Wei Li; Teng Zhou; Qianqian Chen; Fuyu Yang; Taotao Wei
Journal:  Protein Cell       Date:  2013-04-03       Impact factor: 14.870

Review 3.  Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.

Authors:  Emanuel E Strehler
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

4.  Deletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1, 25-dihydroxyvitamin D3.

Authors:  Zachary C Ryan; Theodore A Craig; Adelaida G Filoteo; Jennifer J Westendorf; Elizabeth J Cartwright; Ludwig Neyses; Emanuel E Strehler; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2015-09-21       Impact factor: 3.575

5.  Novel strategies for the treatment of heart failure.

Authors:  Izhak Kehat
Journal:  Rambam Maimonides Med J       Date:  2012-04-30

6.  Amorphous calcium phosphate nanoparticles could function as a novel cancer therapeutic agent by employing a suitable targeted drug delivery platform.

Authors:  Milad Pourbaghi-Masouleh; Vahid Hosseini
Journal:  Nanoscale Res Lett       Date:  2013-10-30       Impact factor: 4.703

7.  Treatment with specific and pan-plasma membrane calcium ATPase (PMCA) inhibitors reduces malaria parasite growth in vitro and in vivo.

Authors:  Puji B S Asih; Josephine E Siregar; Farahana K Dewayanti; Normalita E Pravitasari; Ismail E Rozi; Andita F M Rizki; Rifqi Risandi; Kevin N Couper; Delvac Oceandy; Din Syafruddin
Journal:  Malar J       Date:  2022-06-29       Impact factor: 3.469

8.  Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS-dependent mechanism.

Authors:  Sophronia Lewis; Robert Little; Florence Baudoin; Sukhpal Prehar; Ludwig Neyses; Elizabeth J Cartwright; Clare Austin
Journal:  J Cell Mol Med       Date:  2017-11-30       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.